Advertisement

Background and Pathophysiology of Autoimmune Neutropenia

  • Jacquelyn M. Powers
Chapter

Abstract

Autoimmune neutropenia is estimated to occur in at least 1 in 100,000 children. The majority of patients are affected during the first 2 years of life, with resolution by age 5. Primary autoimmune neutropenia of infancy may present at the time of an acute infection or incidentally when a complete blood count is obtained for another reason. The neutropenia is a result of peripheral destruction due to autoantibody production against antigens on the neutrophil surface, most commonly human neutrophil antigen 1 on the neutrophil immunoglobulin receptor FcγRIIIb. Antibodies often remit within 18–24 months from the time of diagnosis. Most children experience a benign course with limited increased risk of infections. In contrast, secondary autoimmune neutropenia may present at any age with a more variable clinical course. Patients with the latter may have pan-FcγRIIIb autoantibodies and should undergo investigation for other autoimmune or primary immune system disorders.

Keywords

Autoimmune neutropenia Chronic benign neutropenia of childhood 

References

  1. 1.
    Newburger PE, Dale DC. Evaluation and management of patients with isolated neutropenia. Semin Hematol. 2013;50(3):198–206.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Newburger PE. Autoimmune and other acquired neutropenias. Hematol Am Soc Hematol Educ Prog. 2016;2016(1):38–42.Google Scholar
  3. 3.
    Bux J, Behrens G, Jaeger G, Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood. 1998;91(1):181–6.PubMedGoogle Scholar
  4. 4.
    Bruin M, Dassen A, Pajkrt D, Buddelmeyer L, Kuijpers T, de Haas M. Primary autoimmune neutropenia in children: a study of neutrophil antibodies and clinical course. Vox Sang. 2005;88(1):52–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Lyall EG, Lucas GF, Eden OB. Autoimmune neutropenia of infancy. J Clin Pathol. 1992;45(5):431–4.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Farruggia P, Fioredda F, Puccio G, Porretti L, Lanza T, Ramenghi U, et al. Autoimmune neutropenia of infancy: data from the Italian neutropenia registry. Am J Hematol. 2015;90(12):E221–2.CrossRefPubMedGoogle Scholar
  7. 7.
    Farruggia P, Dufour C. Diagnosis and management of primary autoimmune neutropenia in children: insights for clinicians. Ther Adv Hematol. 2015;6(1):15–24.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Taniuchi S, Masuda M, Hasui M, Tsuji S, Takahashi H, Kobayashi Y. Differential diagnosis and clinical course of autoimmune neutropenia in infancy: comparison with congenital neutropenia. Acta Paediatr. 2002;91(11):1179–82.CrossRefPubMedGoogle Scholar
  9. 9.
    Teachey DT, Lambert MP. Diagnosis and management of autoimmune cytopenias in childhood. Pediatr Clin N Am. 2013;60(6):1489–511.CrossRefGoogle Scholar
  10. 10.
    Dinauer MC, Newburger PE. The phagocyte system and disorders of granulopoiesis and granulocyte function. In: Orkin SH, Nathan DG, Ginsburg D, Look AT, Fisher DE, Lux SE, editors. Nathan and Oski’s Hematology of infancy and childhood. 7th ed. Philadelphia, PA: Saunders Elsevier; 2009. p. 1145–9.Google Scholar
  11. 11.
    Bruin MC, von dem Borne AE, Tamminga RY, Kleijer M, Buddelmeijer L, de Haas M. Neutrophil antibody specificity in different types of childhood autoimmune neutropenia. Blood. 1999;94(5):1797–802.PubMedGoogle Scholar
  12. 12.
    Dufour C, Miano M, Fioredda F. Old and new faces of neutropenia in children. Haematologica. 2016;101(7):789–91.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Bussel JB, Abboud MR. Autoimmune neutropenia of childhood. Crit Rev Oncol Hematol. 1987;7(1):37–51.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Pediatric Hematology/OncologyBaylor College of Medicine, Texas Children’s Cancer and Hematology CenterHoustonUSA

Personalised recommendations